阿里拉姆制药盘中异动早盘急速跳水5.05%报315.16美元

市场透视2025-07-07

北京时间2025年07月07日23时04分，阿里拉姆制药（ALNY.us）股票出现异动，股价大幅下挫5.05%。截至发稿，该股报315.16美元/股，成交量46.5632万股，换手率0.36%，振幅3.84%。最近的财报数据显示，该股实现营业收入5.94亿美元，净利润-57.48百万美元，每股收益-0.44美元，毛利5.23亿美元，市盈率-150.43倍。机构评级方面，在所有34家参与评级的机构中...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2549555175?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-07 23:04","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2549555175","market":"us","top_or_hot":-1,"title":"阿里拉姆制药盘中异动 早盘急速跳水5.05%报315.16美元","media":"市场透视","content":"<div>\n<p>北京时间2025年07月07日23时04分，阿里拉姆制药（ALNY.us）股票出现异动，股价大幅下挫5.05%。截至发稿，该股报315.16美元/股，成交量46.5632万股，换手率0.36%，振幅3.84%。最近的财报数据显示，该股实现营业收入5.94亿美元，净利润-57.48百万美元，每股收益-0.44美元，毛利5.23亿美元，市盈率-150.43倍。机构评级方面，在所有34家参与评级的机构中...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707230408a69b3ab3&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>阿里拉姆制药盘中异动 早盘急速跳水5.05%报315.16美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n阿里拉姆制药盘中异动 早盘急速跳水5.05%报315.16美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-07 23:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707230408a69b3ab3&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年07月07日23时04分，阿里拉姆制药（ALNY.us）股票出现异动，股价大幅下挫5.05%。截至发稿，该股报315.16美元/股，成交量46.5632万股，换手率0.36%，振幅3.84%。最近的财报数据显示，该股实现营业收入5.94亿美元，净利润-57.48百万美元，每股收益-0.44美元，毛利5.23亿美元，市盈率-150.43倍。机构评级方面，在所有34家参与评级的机构中...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707230408a69b3ab3&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0797268264.HKD","symbol_name":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (HKD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707230408a69b3ab3&s=b","article_id":"2549555175","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707230408a69b3ab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2549555175","pubTimestamp":1751900647,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年07月07日23时04分，阿里拉姆制药股票出现异动，股价大幅下挫5.05%。截至发稿，该股报315.16美元/股，成交量46.5632万股，换手率0.36%，振幅3.84%。阿里拉姆制药股票所在的生物技术行业中，整体跌幅为0.27%。阿里拉姆制药公司简介：艾拉伦制药是RNA干扰治疗研究的领导者。来自研究合作伙伴的预付费用提高了艾拉伦的现金水平，该公司有望从合作伙伴关系下的药物商业化中看到更多的里程碑和版税。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0797268264.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (HKD) ACC","BK4548":"巴美列捷福持仓","LU0072462343.USD":"贝莱德亚洲巨龙基金","LU0880133367.SGD":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","LU1105468828.SGD":"Allianz Total Return Asian Equity AM DIS H2-SGD","BK4607":"DeepSeek概念股","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU1008478684.HKD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (HKD) ACC","LU0918141705.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AM\" (HKD) INC","LU0918141887.USD":"安联亚洲实际收益股票基金","LU1235294995.USD":"FIDELITY GLOBAL TECHNOLOGY \"A\" (USDHDG) ACC","BK4554":"元宇宙及AR概念","BK4220":"综合零售","LU0348816934.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (USD)","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","BK4531":"中概回港概念","LU1282648689.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AMG\" (USD) INC","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK4526":"热门中概股","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU0651947912.USD":"BGF EMERGING MARKETS EQUITY INCOME \"A5G\" (USD) INC","BK4139":"生物科技","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4502":"阿里概念","BK4575":"芯片概念","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU1769817096.USD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERG MARKETS OPPO \"P\" (USD) INC","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","BK4579":"人工智能","LU1051769294.HKD":"BGF EMERGING MARKETS EQUITY INCOME \"A6\"(HKDHDG) INC","BK4505":"高瓴资本持仓","BK4535":"淡马锡持仓","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","ALNY":"阿尔尼拉姆制药公司","LU0328353924.USD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) \"P\" (USD) ACC","LU1048588211.SGD":"Blackrock Asian Dragon A2 SGD-H","LU1051768304.USD":"贝莱德新兴市场股票收益A6","BK4504":"桥水持仓","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","BK4588":"碎股","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC"},"translate_title":"Aliram Pharmaceuticals' intraday changes plunged 5.05% to $315.16 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALNY":0.9,"ALBmain":0.6},"content_text":"北京时间2025年07月07日23时04分，阿里拉姆制药（ALNY.us）股票出现异动，股价大幅下挫5.05%。截至发稿，该股报315.16美元/股，成交量46.5632万股，换手率0.36%，振幅3.84%。最近的财报数据显示，该股实现营业收入5.94亿美元，净利润-57.48百万美元，每股收益-0.44美元，毛利5.23亿美元，市盈率-150.43倍。机构评级方面，在所有34家参与评级的机构中，71%的券商给予买入建议，26%的券商给予持有建议，3%的券商给予卖出建议。阿里拉姆制药股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为4667.68%、1138.64%、834.45%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为298.32%、122.03%、84.08%。阿里拉姆制药公司简介：艾拉伦制药是RNA干扰(RNAi)治疗研究的领导者。RNA干扰(RNAi)是细胞内一种自然发生的生物通路，用于序列特异性沉默和调控基因表达。艾拉伦有5种药物上市：治疗遗传性转甲状腺素蛋白(hATTR)淀粉样变的Onpattro和Amvuttra，治疗肝性卟啉症的Givlaari，治疗原发性高草酸尿1型的Oxlumo，治疗高胆固醇血症的Leqvio。它也有几个不同治疗领域的临床项目：基因药物；心脏代谢疾病；肝脏感染性疾病以及中枢神经系统/眼部疾病。来自研究合作伙伴的预付费用提高了艾拉伦的现金水平，该公司有望从合作伙伴关系下的药物商业化中看到更多的里程碑和版税。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2549555175","isCrawlerRequest":true}

阿里拉姆制药盘中异动 早盘急速跳水5.05%报315.16美元

精彩评论

阿里拉姆制药盘中异动早盘急速跳水5.05%报315.16美元